Performant Healthcare, Inc. (PHLT)
(Delayed Data from NSDQ)
$7.70 USD
0.00 (0.00%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
PHLT 7.70 0.00(0.00%)
Will PHLT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PHLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PHLT
Performant Healthcare (PHLT) Surges 115.2%: Is This an Indication of Further Gains?
Performant Healthcare (PHLT) Upgraded to Strong Buy: What Does It Mean for the Stock?
PHLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Organon (OGN) Q1 Earnings Surpass Estimates
GoodRx Holdings, Inc. (GDRX) Q4 Earnings Match Estimates
Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates
Other News for PHLT
PHLT's price rises by 0.26% on September 18, though its technical setup remains stable.
PHLT traded flat on September 17, leaving the technical picture intact
The technical outlook for PHLT is unchanged after it falls 0.13% on September 16
PHLT's price rises by 0.13% on September 15, though its technical setup remains stable.
Technical picture remains unchanged for PHLT after it falls 0.13% on September 12